Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
ETON Eton Pharmaceutical
- 12.350
- +0.190+1.56%
Close Dec 13 16:00 ET
- 12.350
- 0.0000.00%
Post 20:01 ET
321.74MMarket Cap-58.81P/E (TTM)
12.590High12.154Low117.06KVolume12.180Open12.160Pre Close1.45MTurnover0.57%Turnover RatioLossP/E (Static)26.05MShares13.98052wk High20.15P/B253.24MFloat Cap3.03052wk Low--Dividend TTM20.51MShs Float13.980Historical High--Div YieldTTM3.58%Amplitude1.950Historical Low12.359Avg Price1Lot Size
Eton Pharmaceutical Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 238.14%2.95M | -82.33%1.26M | -59.75%-2.47M | 41.36%6.82M | -86.37%387K | 151.26%873K | 188.62%7.1M | -226.57%-1.55M | 202.12%4.82M | 155.50%2.84M |
| Net income from continuing operations | 208.29%627K | -166.70%-3.04M | 69.51%-811K | 89.62%-936K | -347.37%-2.26M | 80.99%-579K | 392.62%4.56M | 50.09%-2.66M | -361.43%-9.02M | -12.22%912K |
| Depreciation and amortization | 45.55%278K | 51.74%261K | 18.31%252K | -49.21%901K | 28.97%325K | 12.35%191K | -85.31%172K | 17.68%213K | 283.98%1.77M | 83.94%252K |
| Other non cash items | -2.50%39K | -16.90%59K | -13.79%25K | -7.87%117K | -174.19%-23K | 33.33%40K | 136.67%71K | -19.44%29K | -14.19%127K | -18.42%31K |
| Change In working capital | 161.91%1.29M | 106.86%3.14M | -137,900.00%-2.76M | -53.44%3.6M | 109.62%1.59M | 154.40%491K | -0.13%1.52M | -100.04%-2K | 224.34%7.72M | 110.55%759K |
| -Change in receivables | -74.45%-717K | -201.43%-633K | 18.88%-829K | -143.08%-1.56M | 123.73%84K | 38.10%-411K | -452.63%-210K | -121.86%-1.02M | 166.73%3.62M | 93.04%-354K |
| -Change in inventory | 155.32%130K | 165.96%250K | -1,272.50%-1.41M | -4,957.14%-354K | 284.21%140K | -570.00%-235K | -1,704.76%-379K | 200.00%120K | -101.01%-7K | 64.81%-76K |
| -Change in prepaid assets | -148.77%-159K | 8.19%251K | -58.64%79K | -91.54%161K | -159.03%-588K | 7.95%326K | -73.21%232K | -80.12%191K | 285.38%1.9M | 69.45%-227K |
| -Change in payables and accrued expense | 150.55%2.03M | 74.48%3.27M | -185.05%-603K | 142.10%5.35M | 38.06%1.96M | 60.59%811K | 163.43%1.87M | 267.61%709K | 586.56%2.21M | 223.24%1.42M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 238.14%2.95M | -82.33%1.26M | -59.75%-2.47M | 41.36%6.82M | -86.37%387K | 151.26%873K | 188.62%7.1M | -226.57%-1.55M | 202.12%4.82M | 155.50%2.84M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -1.88M | 72.20%-775K | -6,358.33%-775K | 0 | 0 | 0 | -8.95%-2.79M | 99.63%-12K |
| Net PPE purchase and sale | --0 | --0 | ---14K | --0 | --0 | --0 | --0 | --0 | -105.50%-38K | -200.00%-12K |
| Net intangibles purchase and sale | --0 | --0 | ---1.87M | 71.82%-775K | ---775K | --0 | --0 | --0 | 15.38%-2.75M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | ---1.88M | 72.20%-775K | -6,358.33%-775K | --0 | --0 | --0 | -8.95%-2.79M | 99.63%-12K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -4.34%-385K | 11.84%-216K | -671.43%-378K | -614.18%-957K | -396.97%-294K | -1,154.29%-369K | -309.40%-245K | 87.27%-49K | -134.27%-134K | 45.59%99K |
| Net issuance payments of debt | 0.00%-385K | 0.00%-385K | ---385K | -200.00%-1.16M | ---385K | ---385K | ---385K | --0 | -156.67%-385K | --0 |
| Proceeds from stock option exercised by employees | --0 | 20.71%169K | -94.70%7K | -21.12%198K | -190.91%-90K | -54.29%16K | 19.66%140K | --132K | -53.60%251K | 45.59%99K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---181K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -4.34%-385K | 11.84%-216K | -671.43%-378K | -614.18%-957K | -396.97%-294K | -1,154.29%-369K | -309.40%-245K | 87.27%-49K | -134.27%-134K | 45.59%99K |
| Net cash flow | ||||||||||
| Beginning cash position | -17.95%17.69M | 13.24%16.66M | 31.17%21.39M | 13.18%16.31M | 64.97%22.07M | 26.52%21.57M | -3.42%14.71M | 13.18%16.31M | -32.35%14.41M | -41.09%13.38M |
| Current changes in cash | 409.33%2.57M | -84.85%1.04M | -196.37%-4.73M | 167.67%5.08M | -123.30%-682K | 113.74%504K | 277.44%6.86M | -294.05%-1.6M | 127.57%1.9M | 135.25%2.93M |
| End cash Position | -8.20%20.26M | -17.95%17.69M | 13.24%16.66M | 31.17%21.39M | 31.17%21.39M | 64.97%22.07M | 26.52%21.57M | -3.42%14.71M | 13.18%16.31M | 13.18%16.31M |
| Free cash flow | 238.14%2.95M | -82.33%1.26M | -181.33%-4.36M | 197.10%6.04M | -113.72%-388K | 123.58%873K | 317.82%7.1M | -228.15%-1.55M | 125.48%2.03M | 133.78%2.83M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.